Development of paramagnetic probes for molecular recognition studies in protein kinases

Journal of Medicinal Chemistry

Volumn 51, Issue 12, 2008, Pages 3460-3465

  Vazquez, Jesus ^a   De, Surya K ^a   Chen, Li Hsing ^a   Riel Mehan, Megan ^a   Emdadi, Aras ^a   Cellitti, Jason ^a   Stebbins, John L ^a   Rega, Michele F ^a   Pellecchia, Maurizio ^a  

^a BURNHAM INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INDAZOLE DERIVATIVE; PROTEIN KINASE;

ARTICLE; BINDING SITE; ENZYME ACTIVITY; MOLECULAR MODEL; MOLECULAR RECOGNITION; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; SPIN LABELING; SYNTHESIS; X RAY CRYSTALLOGRAPHY;

BINDING SITES; CYCLIC N-OXIDES; INDAZOLES; JNK MITOGEN-ACTIVATED PROTEIN KINASES; MAGNETIC RESONANCE SPECTROSCOPY; MODELS, MOLECULAR; OLIGOPEPTIDES; PROTEIN BINDING; SPIN LABELS;

EID: 45749113037     PISSN: 00222623     EISSN: None     Source Type: Journal    
DOI: 10.1021/jm800068w     Document Type: Article

References (36)

1. Manning, A. M.; Davis, R. J. Targeting JNK for therapeutic benefit: from junk to gold. Nature Rev. 2003, 2, 554-565.
2. Manning, A. M.; Mercurio, F. Transcription inhibitors in inflammation. Exp. Opin. Invest. Drugs 1997, 6, 555-567.
3. Gum, R.; Wang, H.; Lengyel, E.; Juarez, J.; Boyd, D. Regulation of 92 kDa type IV collagenase expression by the jun aminoterminal kinase and the extracellular signal-regulated kinase-dependent signaling cascades. Oncogene 1997, 14, 1481-1493.
4. Xia, Z.; Dickens, M.; Raingeaud, J.; Davis, R. J.; Greenberg, M. E. Opposing effects of ERK and JNK-p38 MAP kinases on apoptosis. Science 1995, 270, 1326-1331.
5. Le-Niculescu, H.; Bonfoco, E.; Kasuya, Y.; Claret, F.-X.; Green, D. R.; Karin, M. Withdrawal of survival factors results in activation of the JNK pathway in neuronal cells leading to Fas ligand induction and cell death. Mol. Cell. Biol. 1999, 19, 751-763.
6. Lee, Y. H.; Giraud, J.; Davis, R. J.; White, M. F. c-Jun N-terminal kinase (JNK) mediates feedback inhibition of the insulin signaling cascade. J. Biol. Chem. 2003, 278, 2896-2902.
7. Standaert, M. L.; Bandyopadhyay, G.; Galloway, L.; Soto, J.; Ono, Y.; Kikkawa, U.; Farese, R. V.; Leitges, M. Effects of knockout of the protein kinase C β gene on glucose transport and glucose homeostasis. Endocrinology 1999, 140, 4470-4477.
8. Ip, Y. T.; Davis, R. J. Signal transduction by the c-Jun N-terminal kinase (JNK): from inflammation to development. Curr. Opin. Cell Biol. 1998, 10, 205-219.
9. Potapova, O.; Haghighi, A.; Bost, F.; Liu, C.; Birrer, M. J.; Gjerset, R.; Mercola, D. The Jun kinase/stress-activated protein kinase pathway functions to regulate DNA repair and inhibition of the pathway sensitizes tumor cells to cisplatin. J. Biol. Chem. 1997, 272, 14041-14044.
10. Potapova, O.; Gorospe, M.; Bost, F.; Dean, N. M.; Gaarde, W. A.; Mercola, D.; Holbrook, N. J. c-Jun N-terminal kinase is essential for growth of human T98G glioblastoma cells. J. Biol. Chem. 2000, 275, 24767-24775.
11. Kallunki, T.; Deng, T.; Hibi, M.; Karim, M. c-Jun can recruit JNK to phosphorylate dimerization partners via specific docking interactions. Cell 1996, 87, 929-939.
12. Yang, S. H.; Whitmarsh, A. J.; Davis, R. I.; Sharrocks, A. Differential Targeting of MAP kinases to the ETS-domain transcription factor Elk-1. EMBO J. 1998, 17, 1740-1749.
13. Whitmarsh, A. J.; Cavanagh, J.; Tournier, C.; Yasuda, J.; Davis, R. J. A mammalian scaffold complex that selectively mediates MAP kinase activation. Science 1998, 281, 1671-1674.
14. Dickens, M.; Roger, J. S.; Cavanagh, J.; Raitano, A.; Xia, Z.; Halpern, J. R.; Greenberg, M. E.; Sawyer, C. L.; Davis, R. J. A cytoplasmic inhibitor of the JNK signal transduction pathway. Science 1997, 277, 693-696.
15. Bonny, C.; Oberson, A.; Negri, S.; Sauser, C.; Schorderet, D. F. Cell-permeable peptide inhibitors of JNK: novel blockers of beta-cell death. Diabetes 2001, 50, 77-82.
16. Barr, R. K.; Kendrick, T. S.; Bogoyevitch, M. A. Identification of the critical features of a small peptide inhibitor of INK activity. J. Biol. Chem. 2002, 277, 10987-10997.
17. Bennett, B. L.; Sasaki, D. T.; Murray, B. W.; O'Leary, E. C.; Sakata, S. T.; Xu, W.; Leisten, J. C.; Motiwala, A.; Pierce, S.; Satoh, Y.; Bhagwat, S. S.; Manning, A. M.; Anderson, D. W. SP600125, an anthrapyrazolone inhibitor of Jun N-terminal kinase. Proc. Natl. Acad. Sci. U.S.A. 2001, 98, 13681-13686.
18. Heo, Y. S.; Kim, S.-K.; Seo, C. I.; Kim, Y. K.; Sung, B.-J.; Lee, H. S.; Lee, J. I.; Park, S.-Y.; Kim, J. H.; Hwang, K. Y.; Hyun, Y.-L.; Jeon, Y. H.; Ro, S.; Cho, J. M.; Lee, T. G.; Yang, C.-H. Structural basis for the selective inhibition of JNK1 by the scaffolding protein JIP and SP600125. EMBO J. 2004, 23, 2185-2195.
19. Jahnke, W. Spin labels as a tool to identify and characterize protein-ligand interactions by NMR spectroscopy. ChemBioChem 2002, 3, 167-173.
20. Jahnke, W.; Floersheim, P.; Ostermeier, C.; Zhang, X.; Hemmig, R.; Hurth, K.; Uzunov, D. P. NMR reporter screening for the detection of high-affinity ligands. Angew. Chem., Int. Ed. 2002, 41, 3420-3423.
21. Jahnke, W.; Blommers, M. J. J.; Fernandez, C.; Zwingelstein, C.; Amstutz, R. Strategies for the NMR-based identification and optimization of allosteric protein kinase inhibitors. ChemBioChem 2005, 6, 1607-1610.
22. Vazquez, J.; Tautz, L.; Ryan, J. J.; Vuori, K.; Mustelin, T.; Pellecchia, M. Development of molecular probes for second-site screening and design of protein tyrosine phosphatase inhibitors. J. Med. Chem. 2007, 50, 2137-2143.
23. Dalvit, C.; Flocco, M.; Knapp, S.; Mostardini, M.; Perego, R.; Stockman, B. J.; Veronesi, M.; Vasari, M. High-throughput NMR-based screening with competition binding experiments. J. Am. Chem. Soc. 2002, 124, 7702-7709.
24. Shuker, S. B.; Hajduk, P. J.; Meadows, R. P.; Fesik, S. W. Discovering high-affinity ligands for proteins: SAR by NMR. Science 1996, 274, 1531-1534.
25. Becattini, B.; Sareth, S.; Zhai, D.; Crowell, K. J.; Leone, M.; Reed, J. C.; Pellecchia, M. Targeting apoptosis via chemical design: inhibition of bid-induced cell death by small organic molecules. Chem. Biol. 2004, 11, 1107-1117.
26. Becattini, B.; Pellecchia, M. SAR by ILOEs: an NMR-based approach to reverse chemical genetics. Chem. - Eur. J. 2006, 12, 2658-2662.
27. Chen, J.; Zhang, Z.; Stebbins, J. L.; Zhang, X.; Hoffman, R.; Moore, A.; Pellecchia, M. A fragment-based approach for the discovery of isoform-specific p38alpha inhibitors. ACS Chem. Biol. 2007, 2, 329-336.
28. Collot, V.; Dallemagne, P.; Bovy, P. R.; Rault, S. Suzuki-type cross-coupling reaction of 3-iodoindazoles with aryl boronic acids: A general and flexible route to 3-arylindazoles. Tetrahedron 1999, 55, 6917-6922.
29. Collot, V.; Bovy, P. R.; Rault, S. Heck cross-coupling reaction of 3-iodoindazoles with methyl acrylate: a mild and flexible strategy to design 2-aza tryptamines. Tetrahedron Lett. 2000, 41, 4363-4366.
30. Gold, version 2.1; The Cambridge Crystallographic Data Centre: 12 Union Road, Cambridge CB2 1EZ, UK.
31. Jones, G.; Willett, P.; Glen, R. C.; Leach, A. R.; Taylor, R. Development and validation of a genetic algorithm for flexible docking. J. Mol. Biol. 1997, 267, 727-748.
32. Eldridge, M. D.; Murray, C. W.; Auton, T. R.; Paolini, G. V.; Mee, R. P. Empirical scoring functions: I. The development of a fast empirical scoring function to estimate the binding affinity of ligands in receptor complexes. J. Comput.-Aided Mol. Des. 1997, 11, 425-445.
33. Teschner, M.; Henn, C.; Vollhardt, H.; Reiling, S.; Brickmann, J. Texture mapping: A new tool for molecular graphics. J. Mol. Graphics 1994, 12, 98-105.
34. Pearlman, R. S. Concord; Concord: St. Louis, MO; 1998; distributed by Tripos.
35. Stebbins, J. L.; De, S. K.; Machleidt, T.; Becattini, B.; Vazquez, J.; Kuntzen, C.; Chen, L.-H.; Riel-Mehan, M.; Emdadi, A.; Solinas, G.; Karin, M.; Pellecchia, M. Identification of a novel JNK inhibitor targeting JNK-JIP interaction site. Nature 2007, submitted for publication.
36. 50) of an enzymatic reaction. Biochem. Pharmacol. 1973, 22, 3099-3108.